Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
China
· Delayed Price · Currency is CNY 25.33
+0.82 (3.35%)
Apr 11, 2025, 10:45 AM CST
SHE:002773 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 10, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Market Capitalization | 23,454 | 16,955 | 14,426 | 18,711 | 44,373 | 32,296 | Upgrade
|
| Market Cap Growth | 35.06% | 17.53% | -22.90% | -57.83% | 37.39% | 40.74% | Upgrade
|
| Enterprise Value | 17,915 | 12,473 | 11,281 | 15,524 | 42,323 | 30,280 | Upgrade
|
| Last Close Price | 25.50 | 18.13 | 15.32 | 19.73 | 46.48 | 35.45 | Upgrade
|
| PE Ratio | 19.61 | 16.23 | 16.09 | 44.44 | - | 44.97 | Upgrade
|
| Forward PE | 18.75 | 12.75 | 12.75 | 17.93 | 44.75 | 33.57 | Upgrade
|
| PS Ratio | 5.35 | 4.28 | 4.26 | 5.19 | 13.47 | 9.91 | Upgrade
|
| PB Ratio | 2.78 | 2.17 | 2.09 | 3.07 | 7.71 | 6.99 | Upgrade
|
| P/TBV Ratio | 2.88 | 2.27 | 2.20 | 3.22 | 8.46 | 7.90 | Upgrade
|
| P/FCF Ratio | 17.85 | 15.71 | 25.31 | - | - | - | Upgrade
|
| P/OCF Ratio | 13.44 | 13.92 | 15.59 | 37.87 | 162.35 | 39.77 | Upgrade
|
| EV/Sales Ratio | 4.10 | 3.15 | 3.33 | 4.31 | 12.84 | 9.30 | Upgrade
|
| EV/EBITDA Ratio | 11.77 | 9.44 | 11.05 | 28.00 | - | 38.64 | Upgrade
|
| EV/EBIT Ratio | 14.32 | 11.33 | 13.05 | 38.14 | - | 43.84 | Upgrade
|
| EV/FCF Ratio | 13.63 | 11.55 | 19.79 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0 | 0.00 | 0.00 | - | 0 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | 0.00 | 0.01 | - | 0.00 | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.00 | 0.01 | - | - | - | Upgrade
|
| Asset Turnover | 0.50 | 0.49 | 0.46 | 0.52 | 0.51 | 0.59 | Upgrade
|
| Inventory Turnover | 1.17 | 1.20 | 1.25 | 1.33 | 1.31 | 1.02 | Upgrade
|
| Quick Ratio | 7.80 | 7.47 | 5.59 | 5.08 | 3.78 | 3.66 | Upgrade
|
| Current Ratio | 8.43 | 8.11 | 6.10 | 5.54 | 4.04 | 4.05 | Upgrade
|
| Return on Equity (ROE) | 14.72% | 14.01% | 13.31% | 7.10% | -5.20% | 16.50% | Upgrade
|
| Return on Assets (ROA) | 8.88% | 8.47% | 7.36% | 3.65% | -6.31% | 7.83% | Upgrade
|
| Return on Capital (ROIC) | 9.75% | 9.35% | 8.30% | 4.29% | -7.80% | 9.92% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.80% | 14.00% | 12.30% | 6.50% | - | 13.60% | Upgrade
|
| Earnings Yield | 5.09% | 6.16% | 6.21% | 2.25% | -0.61% | 2.22% | Upgrade
|
| FCF Yield | 5.60% | 6.37% | 3.95% | -0.40% | -0.78% | -0.47% | Upgrade
|
| Dividend Yield | 1.55% | 2.10% | 0.98% | 0.51% | 0.21% | 0.79% | Upgrade
|
| Payout Ratio | 29.28% | 13.20% | 10.25% | 21.84% | - | 26.16% | Upgrade
|
| Buyback Yield / Dilution | -0.56% | -0.16% | 0.05% | -5.16% | 0.34% | -0.56% | Upgrade
|
| Total Shareholder Return | 0.99% | 1.93% | 1.03% | -4.65% | 0.56% | 0.24% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.